Company / Working Capital per Share
Dianthus Therapeutics, Inc. /DE/ Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$12.17
FY2025
5-year range
$3.09 / $84.43
FY2021-FY2025
Trend
-31.3%
vs FY2024
Sector context
#36 of 210
Health Care
What the data says
Dianthus Therapeutics, Inc. /DE/'s working capital per share of $12.17 is higher than 83% of companies in the Health Care sector (FY2025). Working Capital per Share has declined for 3 consecutive years, from $84.43 in FY2022 to $12.17 in FY2025.
Based on SEC 10-K filings.
12.17 in FY2025 with a 5-year CAGR of +30.7%. Top quartile in the Health Care sector.
Declined from $32.56 to $12.17 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -47.6%
- 5-Year CAGR
- +30.7%
- 10-Year CAGR
- -
Sector benchmark
-89.7% below sector average
Key checks
Key Insights
- Dianthus Therapeutics, Inc. /DE/'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 31.3% year-over-year.
- Ranks #36 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.17 | -31.3% |
| FY2024 | $17.71 | -45.6% |
| FY2023 | $32.56 | -61.4% |
| FY2022 | $84.43 | +2631.6% |
| FY2021 | $3.09 | -3.1% |
| FY2020 | $3.19 | -21.7% |
| FY2019 | $4.08 | -92.9% |
| FY2018 | $57.37 | +120.3% |
| FY2017 | $26.04 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026